The DOI matches its Crossref record; 313 of the 313 references it cites were found in a registry or an index.
Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Moher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous system
Shughrue, P. J., Lane, M. V., & Merchenthaler, I. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971201)388:4<507::aid-cne1>3.0.co;2-6 · Cited by 2,259
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Sex Differences in Cognitive Abilities
Halpern, D. F. (2000) · Psychology Press eBooks · doi:10.4324/9781410605290 · Cited by 1,970
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
Cited by
Gillies, G. E., & McArthur, S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002071 · Cited by 733
“…are seemingly contradictory reports on the relative contributions of ER and ER to the neuroprotective effects of estrogens in most disease models (Brann et al., 2007; Suzuki et al., 2009), evidence is emerging that both ERs have protective capacity, but they operate via different mechanisms and…”
BackgroundInfluentialProtective actions of sex steroid hormones in Alzheimer’s disease
Pike, C. J., Carroll, J. C., Rosario, E. R., & Barron, A. M. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.015 · Cited by 522
Sex differences in Parkinson’s disease
Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.002 · Cited by 489
Extranuclear Steroid Receptors: Nature and Actions
Hammes, S. R., & Levin, E. R. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0022 · Cited by 475
“Rapid signaling by estrogen has been found to contribute to these sex steroid effects in the brain (102, 103).”
BackgroundAge and Sex Are Critical Factors in Ischemic Stroke Pathology
Roy-O’Reilly, M., & McCullough, L. D. (2018) · Endocrinology · doi:10.1210/en.2018-00465 · Cited by 460
Uncovering the mechanisms of estrogen effects on hippocampal function
Spencer, J. L., Waters, E. M., Romeo, R. D., Wood, G. E., Milner, T. A., & McEwen, B. S. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.08.006 · Cited by 414
Gender differences in Parkinson's disease: Clinical characteristics and cognition
Miller, I. N., & Cronin‐Golomb, A. (2010) · Movement Disorders · doi:10.1002/mds.23388 · Cited by 405
“Investigators in this field agree that further study of both endogenous (reproductive hormones over the lifetime) and exogenous (hormone replacement therapy) estrogen levels in PD patients is needed, and that characteristics of estrogen receptors may prove to be important biomarkers of PD.50,51”
BackgroundInfluentialEstrogen Receptors: Therapies Targeted to Receptor Subtypes
Nilsson, S., & Gustafsson, J.-Å. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.226 · Cited by 370
Astrocytes: Role and Functions in Brain Pathologies
Siracusa, R., Fusco, R., & Cuzzocrea, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01114 · Cited by 340
Almey, A., Milner, T. A., & Brake, W. G. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.06.010 · Cited by 314
Estrogen-induced plasticity from cells to circuits: predictions for cognitive function
Brinton, R. D. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.006 · Cited by 303
Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair
Zárate, S., Stevnsner, T., & Gredilla, R. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00430 · Cited by 285
Inflammation and the two-hit hypothesis of schizophrenia
Feigenson, K. A., Kusnecov, A. W., & Silverstein, S. M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.006 · Cited by 282
Hormones and oxidative stress: an overview
Chainy, G. B. N., & Sahoo, D. K. (2020) · Free Radical Research · doi:10.1080/10715762.2019.1702656 · Cited by 259
Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration
Spence, R. D., & Voskuhl, R. R. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.12.001 · Cited by 258
Rapid Estrogen Signaling in the Brain
Raz, L., Khan, M. M., Mahesh, V. B., Vadlamudi, R. K., & Brann, D. W. (2008) · Neurosignals · doi:10.1159/000111559 · Cited by 201
“Estrogen (17β-estradiol) exerts regulatory effects in a variety of tissues in the body, including the brain, breast, cardiovascular system, uterus and bone [”
BackgroundSelf-citationRonkainen, P. H. A., Kovanen, V., Alén, M., Pöllänen, E., Palonen, E.-M., Ankarberg-Lindgren, C., Hämäläinen, E., Turpeinen, U., Kujala, U. M., Puolakka, J., et al. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91518.2008 · Cited by 168
Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine
Eid, A., Mhatre, I., & Richardson, J. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.005 · Cited by 164
Yang, L.-C., Zhang, Q.-G., Zhou, C.-F., Yang, F., Zhang, Y.-D., Wang, R.-M., & Brann, D. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009851 · Cited by 163
Self-citationKarki, P., Smith, K., Johnson, J., & Lee, E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.01.010 · Cited by 73
Sex Differences in Clinical Features of Early, Treated Parkinson’s Disease
Augustine, E. F., Pérez, A., Dhall, R., Umeh, C. C., Videnovic, A., Cambi, F., Wills, A.-M. A., Elm, J. J., Zweig, R. M., Shulman, L. M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133002 · Cited by 71
Dysregulated Wnt Signalling in the Alzheimer’s Brain
Aghaizu, N. D., Jin, H., & Whiting, P. J. (2020) · Brain Sciences · doi:10.3390/brainsci10120902 · Cited by 70
“Further evidence implies that menopause-related estrogen deprivation increases DKK1 expression in the mammalian hippocampus [109,110].”
BackgroundThe Effect of Systemic Chemotherapy on Neurogenesis, Plasticity and Memory
Wigmore, P. (2012) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_235 · Cited by 66
Crawford, C. A., Baella, S. A., Farley, C. M., Herbert, M. S., Horn, L. R., Campbell, R. H., & Zavala, A. R. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2011-8 · Cited by 47
The role of G protein-coupled estrogen receptor 1 on neurological disorders
Roque, C., Mendes-Oliveira, J., Duarte-Chendo, C., & Baltazar, G. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100786 · Cited by 41
Male/female differences in neuroprotection and neuromodulation of brain dopamine
Bourque, M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00035 · Cited by 40
Premature menopause and risk of neurological disease: Basic mechanisms and clinical implications
Scott, E. L., Zhang, Q.-G., Vadlamudi, R. K., & Brann, D. W. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.01.013 · Cited by 36
Self-citationEndocrine factors in key structural and intracellular changes in depression
Gold, P. W. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.01.003 · Cited by 35
Horowitz-Kraus, T., Brunst, K. J., & Cecil, K. M. (2018) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2018.00466 · Cited by 18
Gender Differences and Prevalence of Mental Health Problems in Students of Healthcare Units
Gitay, M. N., Fatima, S., Arshad, S., Arshad, B., Ehtesham, A., Baig, M. A., Ilyas, M. F., Rizvi, S. F., Farooqui, Q., Masroor, M., et al. (2019) · Community Mental Health Journal · doi:10.1007/s10597-018-0304-2 · Cited by 22
Correlation of brain amyloid with “aerobic glycolysis”: a question of assumptions?
Phelps, M. E., & Barrio, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012684107 · Cited by 12
“Estrogens are known to exert neuroprotective effects (22), and increased expression of SULT1E1 is also known to suppress estrogen effects, which are associated with inflammation in various tissues, including in human cancers.”
BackgroundEndocrine disrupting effects on morphological synaptic plasticity
Zsarnovszky, A., Alymbaeva, D., Jocsak, G., Szabo, C., Mária Schilling-Tóth, B., & Sandor Kiss, D. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2024.101157 · Cited by 7
Metadata
- Authors
- Brann, D. W., Dhandapani, K., Wakade, C., Mahesh, V. B., & Khan, M. M.
- Venue
- Steroids
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 72
- Issue
- 5
- Pages
- 381-405
- ISSN
- 0039-128X (ISSN-L)
- OpenAlex
- W2060838923
- Cited by
- 647
- References
- 313
- FWCI
- 17.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.